top of page


Experimentation at the NIH

Download paper

Link to Brookings Conference on "Building a better NIH"

Argues that the NIH could further its impact by partnering with social scientists and declaring an explicit objective to perform experiments and discover the most effective ways to evaluate and fund science.

The COVID-19 Pandemic and Academic Research Enterprise

in Resilience and Ingenuity: Global Innovation Responses to COVID-19

Download chapter

Link to full e-book

Summarizes evidence surrounding the effect of the pandemic on academic research as of early 2022.

Which Scientists Shifted their Research Focus to the COVID-19 Pandemic?

Download paper

The adjustment costs of science played an important role in shaping which scientists decided to shift the focus of their research to the COVID-19 pandemic.

Towards Recovery: Scientists with Better Ratings of their Institution’s Response to the COVID-19 Pandemic have More Optimistic Forecasts about their Future Research

with Karim Lakhani and Dashun Wang

Download paper

We show how scientists’ forecasts of pandemic-related disruptions to their research depend on the eventual length of the COVID-19 pandemic. Scientists that approve of their institution’s response to the pandemic have more optimistic forecasts, even when controlling for their current level of disruptions and many other confounding factors.

Pharmaceutical Trends, Not What They Seem

with Mark Pauly

In Managing Discovery in the Life Sciences, eds. Philip Rea, Mark Pauly, and Lawton Burns, pp. 18-42. Cambridge: Cambridge University Press, 2018

The pharmaceutical industry might be doing ok despite many concerns.

The Direction of Biomedical Science

Prepared for NBER-IFS International Network on the Value of Medical Research

Download paper

How should the allocation of science in the economy be determined? How do scientists choose to pursue different types of trajectories? How do public policies influence these macro- and micro-level outcomes? This survey outlines longstanding questions and recent research surrounding the economics of science with a focus on biomedical research.


X: The Foghorn Decision

Link to case

How do firms engage with high-risk basic science?

Digital Manufacturing at Amgen

Link to case

What are the tradeoffs of automation in biomedical R&D and production processes?

Kermit PPI

Link to case

Is there a business opportunity in between hospitals and medical device manufacturers?

bottom of page